Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell TherapyHemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasmRecruitingPhase 22026-09-09NCT07003295

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Case Western Reserve UniversityClevelandUnited States219
City of Hope Comprehensive Cancer CenterDuarteUnited States263
Emory Saint Joseph's HospitalAtlantaUnited States175
Emory University Hospital MidtownAtlantaUnited States246
Emory University Hospital/Winship Cancer InstituteAtlantaUnited States299
Johns Hopkins University/Sidney Kimmel Cancer CenterBaltimoreUnited States238
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
University of Kentucky/Markey Cancer CenterLexingtonUnited States240
University of Virginia Cancer CenterCharlottesvilleUnited States206
UPMC Hillman Cancer CenterPittsburghUnited States330
Vanderbilt University/Ingram Cancer CenterNashvilleUnited States259